Covid-19: the Haute Autorité de Santé authorizes the Pfizer/BioNTech vaccine in France

The vaccination campaign will begin on Sunday, December 27. The vaccine “can be used in people 16 years of age and older,” HAS said.

There is no information at this time on the impact of the vaccine on the transmission of the virus.

The Covid-19 vaccine developed by Pfizer and BioNTech “can be used in people 16 years and older», «because of its efficacy and satisfactory safety profile“, Estimated Thursday the High Authority for Health (HAS). There “prioritization strategy» already announced (starting with the populations most at risk of severe form and most exposed to the risk of infection) remains valid for this vaccine, called Comirnaty, adds the opinion of the health authority, which constitutes the last regulatory step before the start of the vaccination campaign on Sunday.

We confirm that this first vaccine does indeed have a place in the vaccine strategy, with regard to both its efficacy and its safety profile, which is excellent news.“, declared the president of the HAS, Dominique Le Guludec, during an online press briefing. “The mathematical modeling that we have carried out confirms our strategy of vaccinating as a priority» the residents of accommodation establishments for the elderly and the personnel at risk who work there, i.e. those whowho have the greatest individual benefit from this vaccination“.

Vaccine campaign

Indeed, if the Pfizer and BioNTech vaccine has demonstrated efficacy “important“to prevent developing the disease Covid-19, “for the moment we have no information on the impact of this vaccine on the transmission of the virus“, underlined Elisabeth Bouvet, president of the commission of the techniques of vaccination of the HAS. Also, the vaccination campaign which will begin on Sunday essentially aims to “reduce mortality and severe formsof the disease andpreserve the health system in France“, she recalled.

“SEE ALSO – Covid-19: “The vaccine rush is not justifiedaccording to Brazilian President Jair Bolsonaro

Leave a Reply

Your email address will not be published.